Halozyme Appoints James Daly to Board of Directors
Halozyme Therapeutics has appointed James Daly to its Board of Directors, with the appointment effective September 28, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.